OHLCX Market Research
Delayed

AMGN

AMGN stands for Amgen Inc., a leading biotechnology company focused on discovering, developing, and delivering innovative human therapeutics.

−0.32 (−0.07%) Nov 20, 2026 19:37 ET Delayed
Open
438.76
High
445.49
Low
434.51
Prev close
438.82
Volume
4M
Avg vol 10
3M

Today · Market closed · opens Mon 9:30 AM

Price

AMGN chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 438.50

Strong sellNeutralStrong buy
Neutral
score −0.06 · 18 signalling
5Buy
7Neutral
6Sell

No clear lean. 5 buy, 7 neutral and 6 sell across 18 signals. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is strong (ADX 29).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 3.74 · Signal 8.58 · Hist −4.84
Sell
ADX 14
Strong trend, −DI slightly ahead
ADX 29.37 · +DI 24.78 · −DI 25.32
Sell
Parabolic SAR 0.02, 0.2
Above price, 36.58 over the close
475.08
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion level with base
Conv 454.45 · Base 454.37 · A 413.50 · B 410.75
Neutral

Momentum

RSI 14
Mid-range, no extreme
42.59
Neutral
Stoch 14, 3
Oversold, %K just crossed over %D
%K 8.06 · %D 6.91
Buy
Stoch RSI 14, 14, 3, 3
Oversold, %K level with %D
%K 0.00 · %D 0.00
Neutral
Williams %R 14
Oversold zone, still rising
−91.94
Buy
CCI 14
Below −100, turning up
−161.83
Buy
MFI 14
Above midpoint, not overbought
53.36
Neutral
ROC 12
Price down 8.36% over 12 bars
−8.36%
Sell
AO 5, 35
Above zero, falling
7.64
Neutral
TRIX 18
Above zero
0.320
Buy
KST 10/15/20/30, 3
Below its signal line
KST 72.57 · Signal 83.44
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.02
Up 479.44 · Mid 458.49 · Low 437.54
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 469.19 · Mid 451.84 · Low 434.49
Neutral

Volume

VWAP 345-bar
Close 23.7% above VWAP
354.49
Buy
Force Index 1
Negative, sellers in control
−1.6M
Sell
ATR
11.58
2.64% of close
A/D Line
43.2M
cumulative
OBV
66.2M
cumulative
Volume Profile
330.98 – 346.28
POC · bull 135.2M · bear 124.3M · 52 / 48
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-2.60%

Change in value over the past month.

3 month return

-1.85%

Change in value over the last three months.

Max drawdown

16.57%

Largest fall from a peak to the low that followed.

Standard deviation

29.59%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.23

Return above the risk-free rate per unit of volatility.

Calmar ratio

2.20

Annualised return against the maximum drawdown.

About

AMGN summary

Loading summary…

Questions

AMGN, answered

Is AMGN a good investment?

Investing in AMGN may be attractive if you believe in the growth potential of the biotechnology sector, but potential investors should conduct thorough research.

What is the historical performance of AMGN?

Historically, AMGN has shown strong performance and resilience, reflecting the growth trends in the biotechnology sector.

How does Amgen contribute to healthcare?

Amgen develops innovative medicines that address serious diseases, improving patient outcomes and enhancing the quality of life for patients globally.

What are the risks associated with investing in AMGN?

Risks include regulatory challenges, competition from generic drugs, and the volatility associated with biotechnology stocks.

How frequently does Amgen report its financial performance?

Amgen reports its financial results on a quarterly and annual basis, offering insights into its earnings and business operations.

What sets Amgen apart from its competitors?

Amgen is recognized for its robust research pipeline, innovative therapies, and commitment to quality in biopharmaceuticals.

Where is Amgen headquartered?

Amgen is headquartered in Thousand Oaks, California, USA.

What is Amgen’s dividend policy?

Amgen has a history of paying dividends and aims to provide consistent returns to its shareholders while also investing in research and development.

How does Amgen generate revenue?

Amgen generates revenue primarily through the sale of its biologic drugs and therapies, as well as licensing agreements and partnerships with other companies.

Can I invest in AMGN through a retirement account?

Yes, AMGN can typically be included in retirement accounts such as IRAs or 401(k)s, depending on your brokerage options.

News

AMGN in the news

Unleash Your AMGN Trading Now

Discover unparalleled trading insights with ohlcx.com. Our automated system offers advanced analysis and technical indicators for AMGN, aimed at optimizing your trading decisions. Boost your investment success with us and get ahead in the market now!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.